| Literature DB >> 30622463 |
Eva Hilland1,2, Nils I Landrø1,2, Catherine J Harmer1,3, Luigi A Maglanoc1,4, Rune Jonassen1,5.
Abstract
Alterations in resting state networks (RSNs) are associated with emotional- and attentional control difficulties in depressed individuals. Attentional bias modification (ABM) training may lead to more adaptive emotional processing in depression, but little is known about the neural underpinnings associated with ABM. In the current study a sample of 134 previously depressed individuals were randomized into 14 days of computerized ABM- or a closely matched placebo training regime followed by a resting state magnetic resonance imaging (MRI) scan. Using independent component analysis (ICA) we examined within-network connectivity in three major RSN's, the default mode network (DMN), the salience network (SN) and the central executive network (CEN) after 2 weeks of ABM training. We found a significant difference between the training groups within the SN, but no difference within the DMN or CEN. Moreover, a significant symptom improvement was observed in the ABM group after training. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT02931487.Entities:
Keywords: attention bias modification training (ABMT); central executive network (CEN); default mode network (DMN); independent component analysis (ICA); major depression (MDD); resting state functional connectivity (RSFC); salience network (SN)
Year: 2018 PMID: 30622463 PMCID: PMC6308203 DOI: 10.3389/fnhum.2018.00508
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Figure 1Flow diagram for enrolment, allocation to active placebo or attentional bias modification (ABM), follow-up after 2 weeks, and analyses in accordance with consort. The current clinical trial (NCT02931487) is an extension of a larger double-blinded randomized clinical trial (RCT; NCT02658682) including 321 patients with a history of depression. The current study is based on a subsample from the main RCT. Only participants that fulfilled the inclusion criteria per protocol was invited to participate in the magnetic resonance imaging (MRI) study, from May 2015 to December, 2016. The sample consists of 136 participants that agreed to participate in the MRI study and had no contraindication for MRI scanning. A total of 134 eligible participants between 18 years and 65 years old were included in MRI analyses. *Excluded due to technical problems with the head coil.
Sample characteristics.
| Placebo ( | ABM ( | Value | Sig. | |
|---|---|---|---|---|
| Age | 39.37 (13.55) | 39.09 (12.80) | 0.02 | 0.90 |
| Gender (females) | 44 | 47 | 1.71 | 0.02 |
| Education level (ISCED) | 5.89 (1.17) | 5.85 (1.27) | 0.06 | 0.84 |
| Medication (SSRI) | 23 | 22 | 0.03 | 0.86 |
| Number of previous MDE | 4.60 (5.33) | 4.79 (7.56) | 0.03 | 0.86 |
| Days between ABM and fMRI | 6.98 (8.43) | 6.66 (6.96) | 0.06 | 0.80 |
| HRSD at baseline | 7.53 (4.69) | 9.56 (6.38) | 4.22 | 0.04 |
This table shows means, standard deviations together with .
Figure 2This image shows the group difference within the salience network (SN) for ABM over placebo (left), together with distribution of connectivity strength Z scores within this cluster (right). Activation height is thresholded at the P < 0.05 (corrected) level.